Cheol-Woo Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Cheol-Woo Kim has a total of 164 co-authors. Here are the top co-authors by number of shared publications:
- Hye-Kyung Park
Department of Internal Medicine, Pusan National University Hospital Pusan National University School of Medicine Busan Republic of Korea
5 shared publications - Joo-Hee Kim
Department of Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang 14068, Republic of Korea
5 shared publications - Young-Il Koh
Department of Allergy and Clinical Immunology, Chonnam National University Hospital, Chonnam National University Medical School, Gwangju, Korea
5 shared publications - Young-Min Ye
Department of Allergy and Clinical Immunology, Ajou University School of Medicine, Suwon 16499, Republic of Korea
5 shared publications - Gyu Young Hur
Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul 08308, Republic of Korea
4 shared publications - Hong Lyeol Lee
Department of Internal Medicine, College of Medicine, Inha University, Incheon, Korea
4 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by Wiley in Case Reports in Medicine
- Vol. 2026 (1)
First Confirmed Case of Tegoprazan‐Induced Anaphylaxis Demonstrated by Drug Provocation Testing
Tegoprazan, a potassium‐competitive acid blocker, is commonly prescribed for the treatment of acid‐related gastrointestinal diseases. Aside from a single reported case of tegoprazan‐induced urticaria, no serious hypersensitivity reactions have been documented. Herein, we present a case of tegoprazan‐induced anaphylaxis that evolved from an earlier and less severe reaction. The first episode manifested as manageable urticarial eruptions and resolved after discontinuation of the medication, whereas re‐exposure provoked immediate anaphylaxis, with the initial cutaneous reaction escalating to systemic involvement with hypotension. A 42‐year‐old woman with nonerosive reflux disease presented to the emergency room (ER) with the sudden onset of a generalized rash after taking medications, including tegoprazan, for 8 days. After medical treatment and drug discontinuation, the patient’s symptoms improved without recurrence. However, 9 days later, immediately after readministration of the same drugs, she experienced severe shortness of breath, dizziness, facial swelling, generalized rash, itching, temporary loss of consciousness, and hypotension. The patient was transferred to the ER, where anaphylaxis was diagnosed. Following the administration of a single dose of intramuscular epinephrine, her systemic symptoms improved. Drug provocation tests (DPTs), together with a high Naranjo score, strongly supported tegoprazan as the culprit drug at the patient level. To our knowledge, this is the first reported case of tegoprazan‐induced anaphylaxis confirmed by a formal diagnostic workup that included DPTs. Physicians should be aware of the potential for severe hypersensitivity reactions to tegoprazan.
- 1 January 2026
- Published by Wiley in Case Reports in Medicine
- Vol. 2026 (1)
Open AccessFirst Confirmed Case of Tegoprazan‐Induced Anaphylaxis Demonstrated by Drug Provocation Testing
Tegoprazan, a potassium‐competitive acid blocker, is commonly prescribed for the treatment of acid‐related gastrointestinal diseases. Aside from a single reported case of tegoprazan‐induced urticaria, no serious hypersensitivity reactions have been documented. Herein, we present a case of tegoprazan‐induced anaphylaxis that evolved from an earlier and less severe reaction. The first episode manifested as manageable urticarial eruptions and resolved after discontinuation of the medication, whereas re‐exposure provoked immediate anaphylaxis, with the initial cutaneous reaction escalating to systemic involvement with hypotension. A 42‐year‐old woman with nonerosive reflux disease presented to the emergency room (ER) with the sudden onset of a generalized rash after taking medications, including tegoprazan, for 8 days. After medical treatment and drug discontinuation, the patient’s symptoms improved without recurrence. However, 9 days later, immediately after readministration of the same drugs, she experienced severe shortness of breath, dizziness, facial swelling, generalized rash, itching, temporary loss of consciousness, and hypotension. The patient was transferred to the ER, where anaphylaxis was diagnosed. Following the administration of a single dose of intramuscular epinephrine, her systemic symptoms improved. Drug provocation tests (DPTs), together with a high Naranjo score, strongly supported tegoprazan as the culprit drug at the patient level. To our knowledge, this is the first reported case of tegoprazan‐induced anaphylaxis confirmed by a formal diagnostic workup that included DPTs. Physicians should be aware of the potential for severe hypersensitivity reactions to tegoprazan.
- Open Access
- 30 September 2024
- Published by Jeju National University Institute for Medical Science in Journal of Medicine and Life Science
- Vol. 21 (3) , 83-91
Adverse drug reactions reported over 5 years in a regional university hospital
Adverse drug reactions (ADRs) are closely associated with increased morbidity and mortality rates, prolonged hospitalization durations, and higher healthcare costs. This study aimed to estimate the incidence, clinical features, and reporting status of ADRs to improve the current ADR reporting system and prevent recurrent ADRs in hospitals. This retrospective study was conducted at a regional referral hospital. Patients diagnosed with ADRs over a 5-year period (2009-2014) were recruited for this study. An ADR was identified as an ADRrelated diagnosis in a patient’s medical record or an ADR registered through the inhospital ADR reporting system. The incidence, culprit drug, clinical manifestations, reporting source, severity, related management, and recurrence rate were assessed. Among 1,112 patients, 1,375 ADR events were collected, an estimated 0.06% of the total number of patient visits. Diagnostic contrast agents (46.4%) were the most common culprit drugs, followed by antibiotics (22.0%), nonsteroidal anti-inflammatory drugs (9.9%), and opioids (4.5%). Skin reactions (67.5%) such as rashes and hives were the most frequent manifestations. Additional ADR-related medical attention was necessary in two thirds of cases. One hundred eighty ADR events (13.1%) were categorized as severe, and 19 patients (1.4%) experienced re-exposure to the culprit drugs. Four patients (0.3%) experienced fatal ADRs. Physicians were the most frequent ADR reporters in the in-hospital ADR reporting system. In conclusion, many ADR events may be overlooked, and re-exposure to causative drugs commonly occurs. Continuous education and maintenance of a reporting system may be important for preventing recurrent ADRs.
- 30 September 2024
- Published by Jeju National University Institute for Medical Science in Journal of Medicine and Life Science
- Vol. 21 (3) , 83-91
Open AccessAdverse drug reactions reported over 5 years in a regional university hospital
Adverse drug reactions (ADRs) are closely associated with increased morbidity and mortality rates, prolonged hospitalization durations, and higher healthcare costs. This study aimed to estimate the incidence, clinical features, and reporting status of ADRs to improve the current ADR reporting system and prevent recurrent ADRs in hospitals. This retrospective study was conducted at a regional referral hospital. Patients diagnosed with ADRs over a 5-year period (2009-2014) were recruited for this study. An ADR was identified as an ADRrelated diagnosis in a patient’s medical record or an ADR registered through the inhospital ADR reporting system. The incidence, culprit drug, clinical manifestations, reporting source, severity, related management, and recurrence rate were assessed. Among 1,112 patients, 1,375 ADR events were collected, an estimated 0.06% of the total number of patient visits. Diagnostic contrast agents (46.4%) were the most common culprit drugs, followed by antibiotics (22.0%), nonsteroidal anti-inflammatory drugs (9.9%), and opioids (4.5%). Skin reactions (67.5%) such as rashes and hives were the most frequent manifestations. Additional ADR-related medical attention was necessary in two thirds of cases. One hundred eighty ADR events (13.1%) were categorized as severe, and 19 patients (1.4%) experienced re-exposure to the culprit drugs. Four patients (0.3%) experienced fatal ADRs. Physicians were the most frequent ADR reporters in the in-hospital ADR reporting system. In conclusion, many ADR events may be overlooked, and re-exposure to causative drugs commonly occurs. Continuous education and maintenance of a reporting system may be important for preventing recurrent ADRs.
- 19 September 2023
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 236, 115734
Simple and robust LC–MS/MS method for quantification of colistin methanesulfonate and colistin in human plasma for therapeutic drug monitoring
- 19 September 2023
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 236, 115734
Simple and robust LC–MS/MS method for quantification of colistin methanesulfonate and colistin in human plasma for therapeutic drug monitoring
- Open Access
- 31 December 2022
- Published by Jeju National University Institute for Medical Science in Journal of Medicine and Life Science
- Vol. 19 (3) , 90-94
Food allergy
Food allergy is one of the adverse food reactions, which is developed by immunological reactions. Food allergy is increasing in prevalence among children and adults. In the diagnosis, food challenge is confirmative with history and laboratory tests. Avoidance of culprit food is the only preventive method, especially in patients with severe symptoms. In some food allergies, crossreactivity among allergens should be considered. Latex-fruit/vegetable syndrome and pollen food allergy syndrome are well-understood phenotypes of food allergy related to cross reaction. Red meat allergy is recently described as one of tick-borne diseases. In a rare phenotype of food-dependent exercise-induced anaphylaxis, factors affecting the absorption of food allergen are important in its pathophysiology.
- 31 December 2022
- Published by Jeju National University Institute for Medical Science in Journal of Medicine and Life Science
- Vol. 19 (3) , 90-94
Open AccessFood allergy
Food allergy is one of the adverse food reactions, which is developed by immunological reactions. Food allergy is increasing in prevalence among children and adults. In the diagnosis, food challenge is confirmative with history and laboratory tests. Avoidance of culprit food is the only preventive method, especially in patients with severe symptoms. In some food allergies, crossreactivity among allergens should be considered. Latex-fruit/vegetable syndrome and pollen food allergy syndrome are well-understood phenotypes of food allergy related to cross reaction. Red meat allergy is recently described as one of tick-borne diseases. In a rare phenotype of food-dependent exercise-induced anaphylaxis, factors affecting the absorption of food allergen are important in its pathophysiology.
- Open Access
- 5 August 2022
- Published by XMLink in Journal of Korean Medical Science
- Vol. 37 (32) , e251
Successful mRNA COVID-19 Vaccination and Colonoscopy After Oral Desensitization in a Patient With Polyethylene Glycol Allergy
Cha B, et al. J Korean Med Sci. 2022 Aug;37(32):e251. https://doi.org/10.3346/jkms.2022.37.e251
- 5 August 2022
- Published by XMLink in Journal of Korean Medical Science
- Vol. 37 (32) , e251
Open AccessSuccessful mRNA COVID-19 Vaccination and Colonoscopy After Oral Desensitization in a Patient With Polyethylene Glycol Allergy
Cha B, et al. J Korean Med Sci. 2022 Aug;37(32):e251. https://doi.org/10.3346/jkms.2022.37.e251
- Open Access
- 1 January 2022
- Published by The Korean Academy of Asthma, Allergy and Clinical Immunology and The Korean Academy of Pediatric Al in Allergy, Asthma & Immunology Research
- Vol. 14 (2) , 147-150
Dupilumab Treatment for Asthma: On the Road to a New Horizon Beyond Ethnic Differences?
Lee YW, et al. Allergy Asthma Immunol Res. 2022 Mar;14(2):147-150. https://doi.org/10.4168/aair.2022.14.2.147
- 1 January 2022
- Published by The Korean Academy of Asthma, Allergy and Clinical Immunology and The Korean Academy of Pediatric Al in Allergy, Asthma & Immunology Research
- Vol. 14 (2) , 147-150
Open AccessDupilumab Treatment for Asthma: On the Road to a New Horizon Beyond Ethnic Differences?
Lee YW, et al. Allergy Asthma Immunol Res. 2022 Mar;14(2):147-150. https://doi.org/10.4168/aair.2022.14.2.147
- Open Access
- 7 May 2020
- Published by Elsevier in Respiratory Medicine Case Reports
- Vol. 30, 101086
An unusual case of herpes simplex virus pneumonia with cavitary and necrotic changes
- 7 May 2020
- Published by Elsevier in Respiratory Medicine Case Reports
- Vol. 30, 101086
Open AccessAn unusual case of herpes simplex virus pneumonia with cavitary and necrotic changes
- Open Access
- 1 January 2020
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 12 (6) , 906-909
Understanding the Impact of Chronic Cough on the Quality of Life in the General Population
Jin HJ, et al. Allergy Asthma Immunol Res. 2020 Nov;12(6):906-909. https://doi.org/10.4168/aair.2020.12.6.906
- 1 January 2020
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 12 (6) , 906-909
Open AccessUnderstanding the Impact of Chronic Cough on the Quality of Life in the General Population
Jin HJ, et al. Allergy Asthma Immunol Res. 2020 Nov;12(6):906-909. https://doi.org/10.4168/aair.2020.12.6.906
- Open Access
- 1 January 2020
- Published by Korean Society of Infectious Diseases and Korean Society for Chemotherapy in Infection & Chemotherapy
- Vol. 52 (2) , 204-211
Pharmacokinetics and Safety of Two Voriconazole Formulations after Intravenous Infusion in Healthy Korean Volunteers
Cho SH, et al. Infect Chemother. 2020 Jun;52(2):204-211. https://doi.org/10.3947/ic.2020.52.2.204
- 1 January 2020
- Published by Korean Society of Infectious Diseases and Korean Society for Chemotherapy in Infection & Chemotherapy
- Vol. 52 (2) , 204-211
Open AccessPharmacokinetics and Safety of Two Voriconazole Formulations after Intravenous Infusion in Healthy Korean Volunteers
Cho SH, et al. Infect Chemother. 2020 Jun;52(2):204-211. https://doi.org/10.3947/ic.2020.52.2.204
- Open Access
- 1 January 2020
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 12 (3) , 496-506
A Prospective Observation of Psychological Distress in Patients With Anaphylaxis
Anaphylaxis is an immediate allergic reaction characterized by potentially life-threatening, severe, systemic manifestations. While studies have evaluated links between serious illness and posttraumatic stress disorder (PTSD), few have investigated PTSD after anaphylaxis in adults. We sought to investigate the psychosocial burden of recent anaphylaxis in Korean adults. A total of 203 (mean age of 44 years, 120 females) patients with anaphylaxis were recruited from 15 university hospitals in Korea. Questionnaires, including the Impact of Event Scale-Revised-Korean version (IES-R-K), the Korean version of the Beck Anxiety Inventory (K-BAI), and the Korean version of the Beck Depression Inventory (K-BDI), were administered. Demographic characteristics, causes and clinical features of anaphylaxis, and serum inflammatory markers, including tryptase, platelet-activating factor, interleukin-6, tumor necrosis factor-α, and C-reactive protein, were evaluated. PTSD (IES-R-K ≥ 25) was noted in 84 (41.4%) patients with anaphylaxis. Of them, 56.0% had severe PTSD (IES-R-K ≥ 40). Additionally, 23.2% and 28.1% of the patients had anxiety (K-BAI ≥ 22) and depression (K-BDI ≥ 17), respectively. IES-R-K was significantly correlated with both K-BAI (r = 0.609, p < 0.0001) and K-BDI (r = 0.550, p < 0.0001). Among the inflammatory mediators, tryptase levels were lower in patients exhibiting PTSD; meanwhile, platelet-activating factor levels were lower in patients exhibiting anxiety and depression while recovering from anaphylaxis. In multivariate analysis, K-BAI and K-BDI were identified as major predictive variables of PTSD in patients with anaphylaxis. In patients with anaphylaxis, we found a remarkably high prevalence of PTSD and associated psychological distresses, including anxiety and depression. Physicians ought to be aware of the potential for psychological distress in anaphylactic patients and to consider psychological evaluation.
- 1 January 2020
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 12 (3) , 496-506
Open AccessA Prospective Observation of Psychological Distress in Patients With Anaphylaxis
Anaphylaxis is an immediate allergic reaction characterized by potentially life-threatening, severe, systemic manifestations. While studies have evaluated links between serious illness and posttraumatic stress disorder (PTSD), few have investigated PTSD after anaphylaxis in adults. We sought to investigate the psychosocial burden of recent anaphylaxis in Korean adults. A total of 203 (mean age of 44 years, 120 females) patients with anaphylaxis were recruited from 15 university hospitals in Korea. Questionnaires, including the Impact of Event Scale-Revised-Korean version (IES-R-K), the Korean version of the Beck Anxiety Inventory (K-BAI), and the Korean version of the Beck Depression Inventory (K-BDI), were administered. Demographic characteristics, causes and clinical features of anaphylaxis, and serum inflammatory markers, including tryptase, platelet-activating factor, interleukin-6, tumor necrosis factor-α, and C-reactive protein, were evaluated. PTSD (IES-R-K ≥ 25) was noted in 84 (41.4%) patients with anaphylaxis. Of them, 56.0% had severe PTSD (IES-R-K ≥ 40). Additionally, 23.2% and 28.1% of the patients had anxiety (K-BAI ≥ 22) and depression (K-BDI ≥ 17), respectively. IES-R-K was significantly correlated with both K-BAI (r = 0.609, p < 0.0001) and K-BDI (r = 0.550, p < 0.0001). Among the inflammatory mediators, tryptase levels were lower in patients exhibiting PTSD; meanwhile, platelet-activating factor levels were lower in patients exhibiting anxiety and depression while recovering from anaphylaxis. In multivariate analysis, K-BAI and K-BDI were identified as major predictive variables of PTSD in patients with anaphylaxis. In patients with anaphylaxis, we found a remarkably high prevalence of PTSD and associated psychological distresses, including anxiety and depression. Physicians ought to be aware of the potential for psychological distress in anaphylactic patients and to consider psychological evaluation.